These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7711362)
1. Should high lipid levels in very old patients be lowered? LaRosa JC Drugs Aging; 1995 Feb; 6(2):85-90. PubMed ID: 7711362 [No Abstract] [Full Text] [Related]
2. Case studies in lipid management. Tallis GA; Popplewell PY; Phillips PJ Aust Fam Physician; 1995 Sep; 24(9):1627-31, 1634-5, 1637. PubMed ID: 7487648 [TBL] [Abstract][Full Text] [Related]
3. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention. Mukherjee S Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508 [No Abstract] [Full Text] [Related]
5. Does the addition of ezetimibe to statins reduce cardiovascular risk? Araya FI; Grassi B Medwave; 2016 Dec; 16(Suppl5):e6632. PubMed ID: 27922588 [TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering therapy and risk of coronary events. Lardinois CK JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463 [No Abstract] [Full Text] [Related]
8. Management of lipid disorders in the elderly. Playford DA; Watts GF Drugs Aging; 1997 Jun; 10(6):444-62. PubMed ID: 9205850 [TBL] [Abstract][Full Text] [Related]
9. [Statin prescription in primary prevention: which cardiovascular risk score should be used in Switzerland?]. Nanchen D; Chiolero A; Marques-Vidal PM; Cornuz J; Waeber G; Vollenweider P; Rodondi N Rev Med Suisse; 2010 Mar; 6(239):488-90, 492-3. PubMed ID: 20373694 [TBL] [Abstract][Full Text] [Related]
10. Usual dietary intake and cardiovascular risk factors in older Brazilian women. Nóbrega OT; Paula RS; Silveira SR; Pires AS; Toledo JO; Moraes CF; Córdova C Aging Clin Exp Res; 2012 Dec; 24(6):669-74. PubMed ID: 21499023 [TBL] [Abstract][Full Text] [Related]
11. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia. van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095 [TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering therapy and risk of coronary events. Mascitelli L; Pezzetta F JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709464 [No Abstract] [Full Text] [Related]
13. Update on statins and other lipid-lowering drugs. Miller CA Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910 [No Abstract] [Full Text] [Related]
14. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients]. Nilsson PM; Attvall S; Båvenholm P Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534 [No Abstract] [Full Text] [Related]
15. Management of lipids in the prevention of cardiovascular events. Glassberg H; Rader DJ Annu Rev Med; 2008; 59():79-94. PubMed ID: 17937591 [TBL] [Abstract][Full Text] [Related]
16. The effect of cardiorespiratory fitness on age-related lipids and lipoproteins. Park YM; Sui X; Liu J; Zhou H; Kokkinos PF; Lavie CJ; Hardin JW; Blair SN J Am Coll Cardiol; 2015 May; 65(19):2091-100. PubMed ID: 25975472 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol and diseases of the cardiovascular system. Skeptical opinions]. Ceremuzyński L; Bednarz B Kardiol Pol; 1991; 35(8):91-4. PubMed ID: 1942762 [No Abstract] [Full Text] [Related]